Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab. [electronic resource]
Producer: 20191226Description: 1413-1423 p. digitalISSN:- 1699-3055
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- Bevacizumab -- therapeutic use
- Biomarkers, Tumor -- analysis
- Brain Neoplasms -- blood supply
- Cerebrovascular Circulation
- DNA Modification Methylases -- metabolism
- DNA Repair Enzymes -- metabolism
- Female
- Gene Amplification
- Genes, erbB-1
- Glioblastoma -- blood supply
- Humans
- Immunohistochemistry
- Ki-67 Antigen -- analysis
- Male
- Methylation
- Microvessels -- pathology
- Middle Aged
- Mitotic Index
- Neoplasm Recurrence, Local -- blood supply
- Retrospective Studies
- Tissue Array Analysis
- Tumor Suppressor Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.